Logo
x

Search

Subscribe Now

splicebio

SpliceBio Receives the US FDA IND Clearance to Initiate P-I/II Trial of SB-007 for Treating Stargardt Disease

SpliceBio Receives the US FDA IND Clearance to Initiate P-I/II Trial of SB-007 for Treating Stargardt Disease

  • December 12, 2024
SpliceBio Signs an Exclusive Collaboration and License Agreement with Spark Therapeutics to Develop Gene Therapy

SpliceBio Signs an Exclusive Collaboration and License Agreement with Spark Therapeutics to Develop Gene Therapy

  • October 17, 2023
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.